Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer-Reference-Cited by-同舟云学术

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer

Published:2006-01-25 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Jaaback Ken,Johnson Nick

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005340.pub2/epdf/full

Reference28 articles.

1. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer;Alberts;New England Journal of Medicine,1996

2. Randomized phase III study of intravenous (IV) paclitaxel and cisplatin versus IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): a Gynecologic Oncology Group trial (GOG 172);Armstrong,2002

3. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest;Gadducci;Gynecologic Oncology,2000

4. A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer;Kirmani;Gynecologic Oncology,1994

5. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group;Markman;Journal of Clinical Oncology,2001

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of postoperative normothermic intraperitoneal chemotherapy on the prognosis of MPM patients receiving CRS+HIPEC: a single-center case-control study;European Journal of Surgical Oncology;2024-09

2. Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer;Journal of Controlled Release;2023-08

3. Role of adjuvant and post-surgical treatment in gynaecological cancer;Best Practice & Research Clinical Obstetrics & Gynaecology;2022-01

4. Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial;Journal for ImmunoTherapy of Cancer;2021-12

5. Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models;Molecules;2021-07-03